As influenza enters its peak season, the innovative drug Marbofloxacin (brand name: SuFuda) remains highly sought after, with reports of supply shortages in certain regions. Roche China responded by stating that the company is placing special emphasis on ensuring the supply of SuFuda this year. With the help of internet hospitals, patients can purchase SuFuda on major online platforms with a prescription. Meituan also stated that the current supply of SuFuda tablets on the platform is sufficient, and they will further collaborate with Roche China to increase the coverage of SuFuda dry suspension to ensure users can smoothly get through the peak flu season. (All Weather Technology)
